Article
Sep 10, 2025

Getting to Know GLP-1 Peptides

There’s been a lot of hype about GLP-1 peptides over the past few years due to their measurable success at helping people lose significant weight and reduce the biomarkers related to type-2 diabetes. 

This blog is a sneak peek from my new book, The Quantum Power of GLP-1 Peptides.

The body naturally produces glucagon-like peptides, which are made up of 30 amino acids, to aid in the digestion and absorption of the foods we eat, regulate appetite, manage blood sugar levels, and contribute to overall metabolic homeostasis. Considered to be both peptides and hormones, these powerful agents also exert control over cognitive functions, anxiety, and neurogenesis. 

Most GLP-1 peptides are produced by the ileum; they are produced in smaller amounts by the intestines and neurons in the brain. GLP-1s are released in response to eating to stimulate insulin secretion, slow digestion, reduce appetite, and make sure blood sugar levels are balanced. Together, these activities comprise the incretin system. 

Different forms of GLP-1s are produced in the body: 

  • GLP-1(7–36)-amide: A truncated form of GLP-1 that is secreted in response to eating
  • GLP-1(7–37): A truncated form of GLP-1 that is the biological precursor to GLP-1(7–36)-amide
  • GLP-1(1–37): A form of GLP-1 that has a lower insulinotropic efficacy than the truncated forms

As I’ve been discussing in Masterminds, courses, and other SSRP gatherings, people with chronic inflammation along with insulin resistance and/or type 2 diabetes have reduced metabolic functioning – they also suffer from an insufficiency in their incretin system and low levels of GLP-1 peptide production, which in turn triggers difficulty in managing blood sugar levels. 

And as we know, type 2 diabetes is closely associated with obesity, heart disease, cancer, and other metabolic disorders that compromise quality of life. 

How GLP-1s Work

GLP-1s work on several different molecular pathways, all of which support metabolism and redox homeostasis. Consider the figure below.

Signaling pathways activated by GLP-1 to promote beta cell mass expansion that supports overall cellular metabolism and redox balance

The Role of the Human Ileum in Gut Peptide Release

Before researchers identified GLP-1 receptor agonists and other gut peptides to address type-2 diabetes and weight loss, they were looking at the function of GLP-1 release in the body and its role in managing metabolism. Specifically, researchers discovered that the L cells found in the ileum, the final and longest part of the small intestine, release two important gut peptides: GLP-1 and peptide tyrosine tyrosine (PYY), both of which contribute to satiety and the regulation of appetite and food intake. 

It is the job of the L cells to secrete GLP-1s and PYY to stimulate insulin secretion from the pancreatic beta cells, inhibit glucagon release, and slow gastric emptying after a meal; we call this the ileal brake system, and it is at the heart of managing blood sugar, appetite, and metabolic efficiency. 

The L cells are stimulated by a range of metabolites, including dietary, microbial, and endogenous molecules to produce short-chain fatty acids (SCFAs). The ileum’s L cells also serve as sensing mechanisms; depending on the nature and degree of nutrients absorbed from food by the ileum, the L cells will release the gut peptides PYY and GLP-1. 

Interestingly, in a study published in 2024, researchers examined the dynamic, wide-ranging molecular environment in the intact human ileum and found that when plant-based foods with intact cellular structures are consumed, they can increase the delivery of nutrients to the ileum, which subsequently can lead to an increased release of satiety peptides (in particular, PYY). 

Of note, the researchers of this study discovered that the structure of the food sources did not impact the delivery of nutrients or the release of gut peptides. In other words, whether we ingest whole foods or break down our food into a liquid structure (as you’d do in a smoothie, for instance), the positive impact on the ileum and satiety is the same. The key player? Fiber. 

A Closer Look at the Role of L Cells

So, why this focus on L cells and the ileum? 

Under normal conditions (i.e., in the absence of insulin resistance, type 2 diabetes, or obesity), L cells have special protein and fatty acid receptors that help raise intracellular calcium levels, which in turn promote the release of GLP-1s. 

In addition, the binding of fatty acids to specific receptors also raises intracellular calcium levels. The now-elevated calcium levels promote exocytosis of GLP-1–containing vesicles, releasing GLP-1 into the circulation. (Note that proteins also promote GLP-1 release, but the mechanics are not yet fully understood.) 

Specifically, in the presence of sodium, L cells promote calcium influx by inducing depolarization; glucose also induces calcium influx by raising adenosine triphosphate (ATP) levels as a result of its catabolism. 

L cells have also been shown to express receptors for metabolic hormones, including insulin, leptin, and gastric inhibitory polypeptide (GIP). The degree to which leptin and insulin stimulate overall GLP-1 secretion is still unclear, but GIP-mediated GLP-1 release has been shown to occur in rodents via acetylcholine release by the enteric nervous system. Supraphysiological concentrations of GIP can also activate GIP receptors on L cells, potentially enhancing GLP-1 secretion. 

The figure below is a visual depiction of the importance of L cells.

Keep in mind how and why L cells produce GLP-1s

The L cell mechanism related to GLP-1 release underscores the different factors related to metabolic homeostasis. In particular, L cells help coordinate glucose metabolism, appetite regulation, and insulin secretion. Once released, GLP-1 enhances insulin secretion from pancreatic beta cells (in a glucose-dependent manner) and improves postprandial glucose control while suppressing glucagon release to prevent unnecessary glucose production. Additionally, GLP-1 slows gastric emptying, reducing the rate of nutrient absorption and promoting satiety, which helps regulate energy balance and prevent overeating. Beyond these immediate metabolic effects, GLP-1 also influences lipid metabolism, inflammation, and cardiovascular health, contributing to overall metabolic stability. 

In Part X, when we dig into the specific GLP-1 RA peptides, keep in mind how the body’s innate GLP-1 release begins as a response to both the foods we eat and the state of our microbiome. In the next section, we will look at how the health of our microbiome can contribute to metabolic flexibility . . . or its degradation.

Taken from The Quantum Power of GLP-1 Peptides.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
VIDEO
Cellular Medicine Mondays
Nov 16, 2026
Ep. 114 Anti-Aging Mini Mastermind Part 4
Preview only
Journal Club – Episode 114

In Part 4 of the Anti-Aging Mini Mastermind, Dr. Seeds explores how NAD synthesis, mitochondrial function, and cellular signaling influence immune function, inflammation, and aging through the lens of cellular medicine.

Preview Only — Become a member for full access
SSRP Institute Nov 12, 2026
FDA Requires New Safety Warnings for GLP-1 Receptor Agonists Due to Potential Vision Risk
BREAKING NEWS [NOVEMBER 12, 2026] – On November 9, the U.S. Food and Drug Administration (FDA) announced new safety labeling requirements for glucagon-like peptide-1 receptor agonists (GLP-1 RAs), citing a potential increased risk of nonarteritic anterior ischemic optic neuropathy (NAION), a rare but serious condition that can cause sudden, painless vision loss, sometimes permanently. The […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Nov 9, 2026
Ep. 113 - Dr. Seeds' Office Hours
Preview only
Dr. Seeds’ Office Hours – Episode 113

1. Dr. Seeds explores the clinical priorities in a 50-year-old female kidney transplant recipient with lupus, chronic steroid use, IBS, fatigue, and reported low morning glucose, focusing on metabolic function, gut health, and preserving immune tolerance. [0:47]

Preview Only — Become a member for full access
Promoitalia Nov 5, 2026
SSRP Institute Welcomes Promoitalia as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [November 5, 2026] — The SSRP Institute announces that Promoitalia has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. Promoitalia is an Italian aesthetic medicine company that develops professional technologies, methodologies, and consumable products for regenerative aesthetics and skin health. Its work combines professional […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Nov 2, 2026
Ep. 112 - Peptide Therapy Gets a Smarter Upgrade
Preview only
Dissecting Protocols – Episode 112

Peptide Therapy Gets a Smarter Upgrade

Dr. Seeds addresses the often-overlooked challenges of peptide purity, patient adherence, and administration. He also shares the journey behind the Redox Smart Pen, highlighting years of collaboration with scientists, physicians, and formulators to help raise the standard for peptide therapy and advance the future of cellular medicine.

Preview Only — Become a member for full access
SSRP Institute Oct 29, 2026
Dr. Seeds and Medivive Announce the Redox Smart Pen: A Novel Technology for Precise Peptide Administration
BREAKING NEWS WILLOUGHBY, Ohio [October 29, 2026] — Dr. Seeds and Medivive announce the launch of the Redox Smart Pen, an innovative pre-filled autoinjector peptide delivery system designed to improve precision and consistency in physician-directed peptide protocols. Importantly, the Redox Smart Pen was developed through a proprietary methodology focused on uniform potency, accuracy of administration, […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Oct 26, 2026
Ep. 111 - Can BPC-157 & HBOT Prevent Amputation?
Preview only
Dissecting Protocols – Episode 111

Can BPC-157 & HBOT Prevent Amputation?

Dr. Seeds explores the potential and limitations of these investigational approaches, emphasizing the importance of blood flow, patient phenotyping, and cellular function in limb salvage. (Question Link)

Preview Only — Become a member for full access
PharmaNutra Oct 22, 2026
SSRP Institute Welcomes PharmaNutra as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [October 22, 2026] — The SSRP Institute announces that PharmaNutra has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. Founded in Italy in 2003, PharmaNutra is a pharmaceutical and nutraceutical company focused on the research, development, and production of nutritional supplements and medical devices. […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Oct 19, 2026
Ep. 110 - The Macrophage Mystery: Decoding Aging
Preview only
Rabbit Holes – Episode 110

The Macrophage Mystery: Decoding Aging

In Part 3 of our Anti-Aging Mini Mastermind, Dr. Seeds explores how aging alters PGE2/EP2 signaling, influencing macrophage metabolism, immune function, and inflammation, and examines potential therapeutic implications.
Articles referenced: (2026 Article) (2021 Article)

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Oct 12, 2026
Ep. 109 - Anti-Aging Mini Mastermind Part 2
Preview only
Journal Club – Episode 109

Anti-Aging Mini Mastermind Part 2

In Part 2 of our Anti-Aging Mini Mastermind series, Dr. Seeds explores how PGE2 signaling and cellular metabolism influence inflammation, cognitive function, and aging, connecting foundational research to emerging discoveries in immunometabolism.  (2026 Article) (2021 Article)

Preview Only — Become a member for full access

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.